Envaste
- Company typePrivate
- Founded2012
- HeadquartersReduit, Mauritius
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Envaste firmographics
Firmographics- Name
- Envaste
- Legal name
- Envaste Ltd.
- Website
- https://envaste.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Envaste industry classification
Industry- Product category
- Urology and Endoscopy Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Kidney Stone Management & Lithotripsy Devices (HLAHAKAI)
- akta.pro secondary industries
- Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
Keywords
Where Envaste is headquartered
LocationHeadquarters
- HQ city
- Reduit
- HQ country
- Mauritius
- HQ region
- Africa
Offices2 records
Markets served
Envaste business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Single-use Medical Device Sales: Envaste generates revenue through the sale of single-use urology and endoscopy instruments. Products include ureteral access sheaths, balloon dilatation catheters, nephrostomy access sheaths, and flexible ureteroscopy disposables. Revenue is primarily transactional, driven by repeat orders from distributor partners across global markets. The single-use nature of devices creates recurring demand from healthcare facilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Envaste product offering
Product offeringCore offering
Envaste designs and manufactures single-use medical devices for therapeutic urology and diagnostic endoscopy, including ureteral access sheaths, balloon dilatation catheters, nephrostomy access sheaths, and flexible ureteroscopy disposables. Products are developed under ISO 13485 and EU MDR 2017/745 compliance and manufactured in Mauritius. The portfolio addresses kidney stone removal (RIRS, PCNL), ureteral stricture dilation, and gastrointestinal endoscopy procedures including biliary stone extraction.
Product overview
Envaste is a specialist designer and manufacturer of single-use therapeutic urology and endoscopy medical devices. The product portfolio consists of two main platform families: the Manawa suction access sheaths (FANS Suction Ureteral Access Sheath and Nephrostomy Suction Access Sheath) designed for RIRS and PCNL procedures to reduce intrarenal pressure and improve visibility; and the Amara balloon dilator platform (standard and wireguided versions) for progressive GI endoscopy balloon dilation including DASE (Difficult Biliary Stone Extraction). The Tahina balloon dilator platform covers both ureteral and nephrostomy applications for urological procedures. All instruments are developed under ISO 13485 quality management and CE/MDR regulatory compliance.
Differentiator
Problem solved
Functional benefit
Brands
- Manawa: Product brand for suction ureteral access sheaths and nephrostomy suction access sheaths, including Manawa FANS (Suction Ureteral Access Sheath) and Manawa Nephrostomy Suction.
- Amara
- Tahina
Products and services
- Manawa Suction (FANS Suction Ureteral Access Sheath) Single-use ureteral access sheath with integrated active suction for RIRS (Retrograde IntraRenal Surgery) procedures. Reduces intrarenal pressure, improves vision, and accelerates stone fragment clearance during flexible ureteroscopy. Designed for urologists performing minimally invasive kidney stone removal.
- Manawa Nephrostomy Suction Access Sheath Single-use nephrostomy access sheath with active suction for PCNL (Percutaneous Nephrolithotomy) procedures. Provides reliable percutaneous access and maintains a clear operative field during stone removal. Designed for urologists performing percutaneous kidney stone removal.
- Tahina Ureteral Balloon Dilator Single-use high-pressure ureteral balloon dilator for challenging anatomical cases in ureteroscopy procedures. Available in multiple French sizes for flexible clinical application. Designed for urologists performing ureteral stricture dilation.
- Tahina Nephrostomy Balloon Dilator Single-use high-pressure nephrostomy balloon dilator for PCNL tract dilatation. Non-compliant balloon rated to 17 ATM enables single-step dilation with integrated reinforced PTFE sheath for immediate tract access, reducing tract trauma and fluoroscopy time. CE-marked under EU MDR 2017/745 and manufactured under ISO 13485. Designed for urologists performing percutaneous nephrolithotomy.
- Amara 3-Stage Balloon Dilator Single-use 3-stage balloon dilator for gastrointestinal endoscopy procedures. Delivers controlled, incremental dilation with three distinct diameters at three separate pressures, eliminating the need for multiple balloon exchanges. Designed for gastroenterologists and endoscopists performing GI stricture treatment.
- Amara Wireguided 3-Stage Balloon Dilator Single-use wireguided 3-stage balloon dilator for ERCP-based biliary dilatation, post-surgical anatomy, and cases requiring fluoroscopic wire confirmation. Features trackability over 0.035 inch guidewires and high column strength catheter shaft for pushability in tortuous anatomy. CE-marked under EU MDR 2017/745 and manufactured under ISO 13485. Designed for gastroenterologists performing complex endoscopic procedures including Difficult Biliary Stone Extraction (DASE).
Quantifiable outcome
- Reduces intrarenal pressure during RIRS procedures through integrated suction technology
- +1 more outcomes
Companies that use Envaste
Customer profileSegments3 records
Ideal customer profiles3 records
Envaste technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Envaste partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Medical Distributors (Europe)coreEnvaste partners with medical device distributors across Europe to supply clinicians with single-use urology and endoscopy instruments. Distributors handle local market access, regulatory compliance, and customer relationships for healthcare facilities within their territories.
- Medical Distributors (MENA)coreEnvaste partners with medical device distributors across the Middle East and North Africa region to distribute single-use instruments to healthcare facilities.
- Medical Distributors (Latin America)coreEnvaste partners with medical device distributors across Latin America to supply clinicians with single-use urology and endoscopy instruments in regional markets.
- Medical Distributors (Asia-Pacific)coreEnvaste partners with medical device distributors across Asia-Pacific to distribute single-use instruments to clinicians in the region.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Envaste competitors and assessment
Company assessmentDirect peers
- Karl Storz: Karl Storz is a specialist in rigid and flexible endoscopy with a strong urology and endourology product line, including reusable and single-use access instruments. Its portfolio directly overlaps Envaste's urology and endoscopy focus.
- Coloplast: Coloplast operates a global urology business (including the former Contigen portfolio) supplying ureteral access sheaths, stents, and stone-management consumables. It competes directly with Envaste in single-use urological instruments sold through hospital and distributor channels.
- Cook Medical: Cook Medical is a direct competitor in urology access sheaths, ureteral dilation, and PCNL access instruments. Its Flexor and Cook Spectrum lines overlap head-to-head with Envaste's Manawa and Tahina portfolios for kidney-stone and endourology procedures.
- Conmed: Conmed has a dedicated urology franchise (urology/gyn) covering ureteral access sheaths, stone-management devices, and dilation products. Its product line closely mirrors Envaste's Manawa and Tahina platforms.
- Richard Wolf: Richard Wolf is a specialist endoscopy and urology manufacturer with a focus on endourology, ureteroscopy, and PCNL instrumentation. It is a comparable mid-size European-headquartered specialist competing for the same endourology hospital accounts as Envaste.
- Applied Medical: Applied Medical manufactures single-use laparoscopic, endoscopic, and urology access devices sold through direct and distributor channels. Its single-use access-sheath and trocar portfolio directly overlaps Envaste's disposable urology strategy.
Broad incumbents
- Olympus Corporation: Olympus is the dominant incumbent in flexible endoscopy and endoscopy accessories, including GI balloon dilators and single-use endoscopic devices. Envaste's Amara 3-Stage Balloon Dilator platform competes in the same GI endoscopy dilation category where Olympus has scale advantages.
- Stryker: Stryker's endoscopy / instruments division supplies urology, GI, and surgical single-use devices globally. As a broad incumbent with strong hospital relationships, it competes for procurement contracts that Envaste's distributors also pursue.
- Boston Scientific: Boston Scientific is a global medical device incumbent with a dedicated Urology and Pelvic Health business that includes ureteral access sheaths, stone-management devices, and single-use flexible ureteroscopy consumables. It is the most cited large competitor in RIRS and stone-management, the same clinical niche Envaste targets with the Manawa FANS sheath.
Emerging players
- Ambu A/S: Ambu is a single-use endoscopy specialist that has expanded aggressively into disposable ureteroscopes and endoscopy consumables. It represents the single-use-disruption thesis applied to endourology — adjacent to Envaste's reusable-replacement strategy in ureteroscopy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Envaste compliance and trust
Trust signalCompliance3 records
Envaste financial estimates
Financial estimateRevenue estimate
Valuation estimate
Envaste leadership team
Management profileNumber of profiles
Profiles3 records
Envaste funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Envaste M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Envaste
What does Envaste do?
Envaste designs and manufactures single-use medical devices for therapeutic urology and diagnostic endoscopy, including ureteral access sheaths, balloon dilatation catheters, nephrostomy access sheaths, and flexible ureteroscopy disposables. Products are developed under ISO 13485 and EU MDR 2017/745 compliance and manufactured in Mauritius. The portfolio addresses kidney stone removal (RIRS, PCNL), ureteral stricture dilation, and gastrointestinal endoscopy procedures including biliary stone extraction.
Is Envaste a public or private company?
Envaste is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Envaste founded?
Envaste was founded in 2012. It employs 11 to 50 people.
Where is Envaste based?
Envaste is headquartered in Reduit, Mauritius, in the Africa region.
How does Envaste make money?
One revenue line is on record: single-use Medical Device Sales.
Who are Envaste's main competitors?
Direct peers on record are Karl Storz, Coloplast, Cook Medical, Conmed, Richard Wolf and Applied Medical. Broad incumbents are Olympus Corporation, Stryker and Boston Scientific. Ambu A/S is listed as an emerging player.
Does Envaste have an API?
No public API is recorded for Envaste.
What industry is Envaste in?
Envaste's product category is Urology and Endoscopy Medical Devices. Its primary akta.pro industry code is HLAHAKAI, Kidney Stone Management & Lithotripsy Devices, with a secondary code of HLAKAOAF, Endourology & Minimally Invasive Urologic Surgery. Its NAICS code is 339113 and its SIC code is 3841.